#USA #Orlando #Volta Labs #Watchmaker Genomics #Callisto Kit

Introduction to the Callisto™ Complete Kit

At the Advances in Genome Biology and Technology Convention (AGBT) 2026, held in Orlando, Florida, a significant breakthrough in genomic research was unveiled. Volta Labs, renowned for its leadership in sample preparation automation for next-generation sequencing (NGS), in collaboration with Watchmaker Genomics, introduced the Callisto™ Complete Kit for preparing DNA EF libraries. This innovation is poised to transform the methodologies employed in genomic sequencing, particularly for laboratories that prioritize efficiency and accuracy.

The Significance of the Callisto™ Complete Kit

The Callisto™ Complete Kit represents a fusion of advanced sample preparation chemistry with state-of-the-art automation technologies. This powerful combination aims to deliver a fully automated workflow for Whole Genome Sequencing (WGS), eliminating the need for PCR while ensuring high-quality and reproducible results. The trend toward PCR-free workflows has gained momentum in clinical and translational research environments, as it minimizes amplification bias and sequencing artifacts, ultimately leading to more consistent genomic coverage across various regions, even those with high GC content.

Challenges in Traditional Library Preparation

Historically, the manual preparation of library samples has posed significant challenges, particularly regarding reproducibility and accuracy. Fluctuations in operator technique can introduce variability that compromises the integrity of sequencing results. The Callisto™ kit addresses these challenges by automating liquid handling, which significantly reduces the potential for human error and enhances overall workflow efficiency. As a result, laboratory personnel can redirect their efforts towards more high-value tasks rather than routine sample preparations.

Voices from the Leaders

Udayan Umapathi, CEO of Volta Labs, shared insights into the motivation behind developing the Callisto™ kit: "We designed Callisto to simplify and make DNA sample preparation for sequencing more accessible. With its intuitive design, laboratories can execute a complete genomic sequencing workflow without the need for PCR through a single-click process, enabling consistent, high-quality outcomes with manageable throughput."

In agreement, Trey Foskett, CEO of Watchmaker Genomics, highlighted the importance of high-performance chemistry for PCR-free full genome sequencing: "For clinical and translational labs that require fast, reliable solutions, but don't operate at large scales, the Callisto™ Complete Kit provides a straightforward and optimized method to confidently implement PCR-free full genomic sequencing." The collaborative efforts between these two innovative companies reflect a deep commitment to advancing genomic research while enhancing lab productivity.

Unveiling the Future at AGBT 2026

To celebrate this monumental launch, Volta Labs and Watchmaker Genomics will host a joint presentation at AGBT 2026 on February 24th at 8:30 AM in the Fulton Suite. Attendees can expect to witness the Callisto™ Complete Kit in action as both teams demonstrate the streamlined, automated workflow for PCR-free genomic sequencing. Participants will have the opportunity to engage directly with the developers and gain deeper insights into this groundbreaking technology.

About Volta Labs and Watchmaker Genomics

Volta Labs pioneers a new future for sequencing sample preparation by merging digital fluidics, modular workflows, and comprehensive automation into a single platform that equips labs for superior NGS library preparation.

Headquartered in Boston, Massachusetts, Volta Labs continues to innovate in the field of genomic research.

Watchmaker Genomics focuses on developing high-performance tools that propel genomic research and clinical applications forward. With expertise in protein engineering and cutting-edge sequencing, Watchmaker offers precision reagents and platforms designed to enhance molecular analysis efficiency and cost-effectiveness, aiming to drive revolutionary innovations in cancer detection, epigenetics, and liquid biopsy applications.

Conclusion

As genomic research continues to evolve, the introduction of the Callisto™ Complete Kit marks a pivotal advancement in laboratory automation and efficiency. With heightened accuracy and ease of use, the future of genomic sequencing looks brighter than ever. The collaboration between Volta Labs and Watchmaker Genomics signifies a remarkable leap toward achieving better results in genetic research and clinical diagnostics.